Floatz logo

1,379 assets in Cancer

Therapeutic assets addressing Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
rp2
Cancer
Replimune, Inc.P1C (37)
Sti-1386
Cancer
Sorrento Therapeutics, Inc.P1C (37)
sv-101
Cancer
Williams Cancer FoundationP1C (37)
Tavo412
Cancer
Tavotek BiotherapeuticsP1C (37)
Ttx-080
Cancer
Tizona Therapeutics, IncP1C (37)
wtx212a
Cancer
Sun Yat-sen UniversityP1C (37)
[111in]-fpi-2107
Cancer
AstraZenecaP1C (36)
[177lu]lu-xt117
Cancer
Ruimin WangP1C (36)
177Lu-TLX250
Cancer
Telix Pharmaceuticals (Innovations) Pty LimitedP1C (36)
225ac-fapi-xt
Cancer
Xiaorong SunP1C (36)
[225ac]-fpi-2068
Cancer
AstraZenecaP1C (36)
89Zr-DFO-REGN5054
Cancer
Regeneron PharmaceuticalsP1C (36)
89Zr-S095012
Cancer
Institut de Recherches Internationales ServierP1C (36)
Abbv-400
Cancer
AbbVieP1C (36)
Abbv-706
Cancer
AbbVieP1C (36)
abl103
Cancer
ABL Bio, Inc.P1C (36)
abl503
Cancer
ABL Bio, Inc.P1C (36)
Abm-168
Cancer
ABM Therapeutics CorporationP1C (36)
Abx-001
Cancer
Abalos Therapeutics GmbHP1C (36)
Acc-1898
Cancer
AccSalus Biosciences, Inc.P1C (36)
Acm-Cpg
Cancer
National Cancer Centre, SingaporeP1C (36)
acr246 for
Cancer
Hangzhou Adcoris Biopharmacy Co., LtdP1C (36)
Adce-T02
Cancer
Adcendo ApSP1C (36)
ak146d1 for
Cancer
AkesoP1C (36)
am-928
Cancer
AcadeMab Biomedical Inc.P1C (36)
Amg 355
Cancer
AmgenP1C (36)
Amt-151
Cancer
Multitude Therapeutics Inc.P1C (36)
Amt-562
Cancer
Multitude Therapeutics (Australia) Pty LtdP1C (36)
AN4005
Cancer
Adlai Nortye Biopharma Co., Ltd.P1C (36)
ap505
Cancer
AP Biosciences Inc.P1C (36)
Apg 2449
Cancer
Ascentage Pharma Group Inc.P1C (36)
Apr-1051
Cancer
Aprea TherapeuticsP1C (36)
arc101
Cancer
Third Arc BioP1C (36)
ask120067
Cancer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.P1C (36)
Askc202
Cancer
Jiangsu Aosaikang Pharmaceutical Co., Ltd.P1C (36)
Askg315
Cancer
AskGene Pharma, Inc.P1C (36)
asp1002
Cancer
Astellas Pharma Global Development, Inc.P1C (36)
asp2074
Cancer
Astellas Pharma Global Development, Inc.P1C (36)
at1019
Cancer
The Affiliated Hospital of Xuzhou Medical UniversityP1C (36)
Atg-018
Cancer
Antengene Discovery LimitedP1C (36)
Atg-031
Cancer
Antengene Biologics LimitedP1C (36)
Ati-2231
Cancer
Washington University School of MedicineP1C (36)
Atv-1601
Cancer
Atavistik Bio, IncP1C (36)
Atx-295
Cancer
Accent TherapeuticsP1C (36)
Atx-559
Cancer
Accent TherapeuticsP1C (36)
Axt-1003
Cancer
Axter Therapeutics (Beijing) Co., LtdP1C (36)
b4t2-001 autologous car-t
Cancer
Shanghai East HospitalP1C (36)
b4t2-001 autologous car t cells
Cancer
Shanghai East HospitalP1C (36)
ba1202
Cancer
Shandong Boan Biotechnology Co., LtdP1C (36)
bal0891
Cancer
SillaJen, Inc.P1C (36)
Showing 851 to 900 of 1,379 assets
PreviousPage 18 of 28Next